| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/09/2006 | EP1686959A2 Pharmaceutical formulations employing short-chain sphingolipids and their use |
| 08/09/2006 | EP1686958A1 Controlled food effect composition |
| 08/09/2006 | EP1686952A1 Use of licocalchone a or of an extract containing licocalchone a from radix glycyrrhizae inflatae against skin aging |
| 08/09/2006 | EP1686951A1 Combined cosmetic or therapeutic preparation |
| 08/09/2006 | EP1686949A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 08/09/2006 | EP1686947A2 Method for the production of bioactive substances from the novel actinomycete taxon mar2 (marinophilus) |
| 08/09/2006 | EP1686927A2 Gamma-tocopherol therapy for restenosis prevention |
| 08/09/2006 | EP1597253B1 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 08/09/2006 | EP1587812B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 08/09/2006 | EP1575559B1 Dosing aerosols containing lecithin as a surface-active substance |
| 08/09/2006 | EP1572666B1 3h-quinazolin-4-one derivatives |
| 08/09/2006 | EP1565481B1 Antiviral nucleoside derivatives |
| 08/09/2006 | EP1560855B1 Polysaccharide of echinacea angustifolia |
| 08/09/2006 | EP1560822B1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors |
| 08/09/2006 | EP1549308B1 Protecting a patient from possible adverse effects of inhibition of the SHH- signaling pathway by suppressing testosterone |
| 08/09/2006 | EP1537114B1 Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 08/09/2006 | EP1511748B1 8-fluorimidazo(1,2-a)pyridine derivatives as ligands for gaba receptors |
| 08/09/2006 | EP1499175A4 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 08/09/2006 | EP1478638B1 Purification of citalopram |
| 08/09/2006 | EP1472249B1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments |
| 08/09/2006 | EP1458387B1 Orodispersible tablets containing fexofenadine |
| 08/09/2006 | EP1456351B1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 08/09/2006 | EP1455779B1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1448179B1 Substituted bicyclo 3.3.1 nonan-2,4,9-triones as pharmaceutical active ingredients |
| 08/09/2006 | EP1446124B1 Combination therapy comprising zd6474 and a taxane |
| 08/09/2006 | EP1441737B1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 08/09/2006 | EP1441730B1 Hydrazono-malonitriles |
| 08/09/2006 | EP1401806B1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 08/09/2006 | EP1399442B1 Cak inhibitors and uses thereof |
| 08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
| 08/09/2006 | EP1395238B1 Skin preparation |
| 08/09/2006 | EP1383483A4 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP1368015B1 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function |
| 08/09/2006 | EP1363637B1 Pyrimidine compounds and methods for their preparation |
| 08/09/2006 | EP1354032B1 Gene regulation therapy involving ferritin |
| 08/09/2006 | EP1331858B1 Synergistic antioxidant combination of delta tocols and polyphenols |
| 08/09/2006 | EP1329456B1 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1317451B1 Chemokine receptor binding heterocyclic compounds |
| 08/09/2006 | EP1315491B1 Use of substituted pyrazoles for the manufacture of a medicament for the treatment of allergies |
| 08/09/2006 | EP1300411B1 Novel disaccharides with anti-arthritic action |
| 08/09/2006 | EP1276460B1 Use of preparations containing an extract of the plant argania spinosa in cosmetic care products for hair and skin |
| 08/09/2006 | EP1267863B1 Composition consisting of propionyl l-carnitine and glycine for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents |
| 08/09/2006 | EP1263423B1 Composition for the prevention and/or treatment of vascular diseases, consisting of propionyl l-carnitine and coenzyme q10 |
| 08/09/2006 | EP1252889B1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1227859B1 Neurophilin ligands for treating ocular conditions |
| 08/09/2006 | EP1224168B1 Antifungal enediynes |
| 08/09/2006 | EP1221940B1 Liposome formulation of 6,9-bis- (2-aminoethyl)-amino|benzo g|isoquinoline-5,10-dione dimaleate |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | EP1185267B1 Dermal anesthetic agents |
| 08/09/2006 | EP1179346B1 Remedies for glomerulosclerosis |
| 08/09/2006 | EP1178782B1 Transdermal therapeutic system (tts) containing tolterodine |
| 08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
| 08/09/2006 | EP1165099B1 Angiotensin ii and analogs thereof for limiting scar and adhesion formation |
| 08/09/2006 | EP1160330B1 Substances wk-5344a and wk-5344b and process for producing the same |
| 08/09/2006 | EP1148881B1 USE OF PYRIDAZINO ¬4,5-(b)|-INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS |
| 08/09/2006 | EP1144003B1 Methods and devices for delivery of agents to breast milk ducts |
| 08/09/2006 | EP1143981B1 Use of n-glycolneuraminic acid and its derivatives for the manufacture of a medicament for the treatment of hiv infections |
| 08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
| 08/09/2006 | EP1135135A4 Chk1 kinase inhibitors |
| 08/09/2006 | EP1107765B1 3-deazaadenosine used in the prevention of atherosclerosis and graft vasculopathy |
| 08/09/2006 | EP1104302A4 Prophylactic treatments of neovascularisation in macular degeneration |
| 08/09/2006 | EP1083873B1 Heterocyclic thioester and ketone hair growth compositions and uses |
| 08/09/2006 | EP1077722B1 Methods and products for inducing mucosal immunity |
| 08/09/2006 | EP1076553B1 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and uses |
| 08/09/2006 | EP1060177B1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same |
| 08/09/2006 | EP1033979B1 Combination of cyp2a enzyme inhibitors and nicotine and their therapeutic use |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | EP1007098B1 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides |
| 08/09/2006 | EP0988301B1 Imidazolyl-cyclic acetals |
| 08/09/2006 | EP0920305B1 Identification of genes altered in multiple myeloma |
| 08/09/2006 | EP0910659B1 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 08/09/2006 | EP0877733B1 Process for production of piperidine derivatives |
| 08/09/2006 | EP0752004B1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 08/09/2006 | CN1816626A Antisense oligonucleotide having anticancerous activity |
| 08/09/2006 | CN1816625A Dna-based aptamers for human cathepsin g |
| 08/09/2006 | CN1816573A Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis |
| 08/09/2006 | CN1816560A Novel fusidic acid derivatives |
| 08/09/2006 | CN1816558A Modified fluorinated nucleoside analogues |
| 08/09/2006 | CN1816557A Novel 14 and 15 membered ring compounds |
| 08/09/2006 | CN1816551A Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 08/09/2006 | CN1816550A Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators |
| 08/09/2006 | CN1816549A Inhibitors of phosphatidylinositol 3-kinase |
| 08/09/2006 | CN1816548A Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 08/09/2006 | CN1816547A Oxazolidinone antibiotics and derivatives thereof |
| 08/09/2006 | CN1816546A Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 08/09/2006 | CN1816545A Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 08/09/2006 | CN1816544A Immunosuppressant compounds and compositions |
| 08/09/2006 | CN1816543A Indole derivatives with apoptosis-inducing effect |
| 08/09/2006 | CN1816542A 2,4-bis (trifluoroethoxy)pyridine compound and drug containing the compound |
| 08/09/2006 | CN1816541A Substituted-1-phthalazinamines as vr-1 antagonists |
| 08/09/2006 | CN1816538A Preventive or therapeutic composition for viral infectious disease |
| 08/09/2006 | CN1816536A Regulator of cannabinoid receptor |
| 08/09/2006 | CN1816534A Oxazolidinone antibiotics and derivatives thereof |
| 08/09/2006 | CN1816533A Pharmaceutical composition comprising valsartan |
| 08/09/2006 | CN1816531A Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/09/2006 | CN1816530A Opthalmic compositions for treating ocular hypertension |